Kassaflöde Zealand Pharma A/S

Aktier

ZEAL

DK0060257814

Bioteknik och medicinsk forskning

Marknaden stängd - Nasdaq Copenhagen Andra börsplatser 17.20.00 2026-01-23			5-dagars förändring	Förändring 1 jan.
426,00 ^DKK	−1,78 %		+1,55 %	−8,66 %

01-16	SEB listar nordiska favoriter för Q1, en svensk kvartett av mindre bolag mest intressant	FW
01-15	Zealand Pharma A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 01:30 PM

090cd5823d7bc258660e08.VUGGTvlYVrrNFXU_LhkQJ4I60o6l89YLNGsy9xaxQgs.CgLCf8A9PcCnWx9qH0xReOlopOzrpb5acR1KmHXlJ10cJ9QXjCwj4JtgIA

Publicerade finansiella data: ZEALAND PHARMA A/S

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2020	2021	2022	2023	2024
Revenues	353 mn	293 mn	104 mn	343 mn	62,69 mn
Total Revenues	353 mn	293 mn	104 mn	343 mn	62,69 mn
Cost of Goods Sold, Total	90,56 mn	119 mn	-	3,2 mn	7,87 mn
Gross Profit	263 mn	174 mn	104 mn	340 mn	54,82 mn
Selling General & Admin Expenses, Total	468 mn	636 mn	270 mn	216 mn	404 mn
Stock-Based Compensation (IS)	-	-	−11,24 mn	-	-
R&D Expenses	604 mn	588 mn	612 mn	685 mn	920 mn
Other Operating Expenses	−602 tn	−759 tn	48,27 mn	-	-
Other Operating Expenses, Total	1,07 md	1,22 md	918 mn	901 mn	1,32 md
Operating Income	−809 mn	−1,05 md	−814 mn	−561 mn	−1,27 md
Interest Expense, Total	−2,9 mn	−4,09 mn	−57,79 mn	−25,83 mn	−34,05 mn
Interest And Investment Income	1,09 mn	44 tn	6,54 mn	45,32 mn	170 mn
Net Interest Expenses	−1,81 mn	−4,05 mn	−51,25 mn	19,49 mn	136 mn
Currency Exchange Gains (Loss)	−39,49 mn	39,32 mn	25,6 mn	−9,71 mn	18,29 mn
Other Non Operating Income (Expenses)	−4,83 mn	−3,47 mn	11,01 mn	−1,99 mn	−17,46 mn
EBT, Excl. Unusual Items	−855 mn	−1,02 md	−829 mn	−553 mn	−1,13 md
Restructuring Charges	-	-	−19,1 mn	-	-
Merger & Related Restructuring Charges	−7,1 mn	-	-	-	-
Gain (Loss) On Sale Of Investments	−1,17 mn	−6,36 mn	2,34 mn	−8,84 mn	52,34 mn
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	−12,74 mn	−2,17 mn	−3,99 mn	−11 mn	-
Legal Settlements	-	-	-	-	−3,14 mn
Other Unusual Items	36,4 mn	-	−123 mn	−136 mn	-
EBT, Incl. Unusual Items	−840 mn	−1,03 md	−972 mn	−709 mn	−1,08 md
Income Tax Expense	7,08 mn	−8,79 mn	−6,43 mn	−5,13 mn	−4,62 mn
Earnings From Continuing Operations	−847 mn	−1,02 md	−966 mn	−704 mn	−1,08 md
Earnings Of Discontinued Operations	-	-	−237 mn	-	-
Net Income to Company	−847 mn	−1,02 md	−1,2 md	−704 mn	−1,08 md
Net Income - (IS)	−847 mn	−1,02 md	−1,2 md	−704 mn	−1,08 md
Net Income to Common Incl Extra Items	−847 mn	−1,02 md	−1,2 md	−704 mn	−1,08 md
Net Income to Common Excl. Extra Items	−847 mn	−1,02 md	−966 mn	−704 mn	−1,08 md
Per aktie poster
Net EPS - Basic	−22,07	−23,75	−26,02	−12,44	−16,24
Basic EPS - Continuing Operations	−22,07	−23,75	−20,9	−12,44	−16,24
Basic Weighted Average Shares Outstanding	38,37 mn	42,87 mn	46,2 mn	56,59 mn	66,43 mn
Net EPS - Diluted	−22,07	−23,75	−26,02	−12,44	−16,24
Diluted EPS - Continuing Operations	−22,07	−23,75	−20,9	−12,44	−16,24
Diluted Weighted Average Shares Outstanding	38,37 mn	42,87 mn	46,2 mn	56,59 mn	66,43 mn
Normalized Basic EPS	−13,93	−14,85	−11,21	−6,11	−10,66
Normalized Diluted EPS	−13,93	−14,85	−11,21	−6,11	−10,66
American Depositary Receipts Ratio (ADR)	0,2	0,2	0,2	0,2	0,2
Kompletterande punkter
EBITDA	−792 mn	−1,02 md	−727 mn	−555 mn	−1,26 md
EBITA	−802 mn	−1,04 md	−814 mn	−561 mn	−1,27 md
EBIT	−809 mn	−1,05 md	−814 mn	−561 mn	−1,27 md
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	−0,84	0,86	0,66	0,72	0,43
Normalized Net Income	−534 mn	−637 mn	−518 mn	−346 mn	−708 mn
Interest on Long-Term Debt	7,72 mn	7,56 mn	57,79 mn	28,98 mn	40,9 mn
Kompletterande driftskostnadsposter
Selling and Marketing Expenses	273 mn	375 mn	32,3 mn	30,63 mn	88,12 mn
General and Administrative Expenses	196 mn	261 mn	237 mn	185 mn	316 mn
Research And Development Expense From Footnotes	604 mn	588 mn	614 mn	685 mn	920 mn
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., COGS (Total)	-	521 tn	-	-	-
Stock-Based Comp., R&D Exp. (Total)	14 mn	22,16 mn	33,84 mn	29,76 mn	41,26 mn
Stock-Based Comp., S&M Exp. (Total)	6,04 mn	2,26 mn	649 tn	1,73 mn	3,47 mn
Stock-Based Comp., G&A Exp. (Total)	10,44 mn	27,97 mn	31,7 mn	29,94 mn	42,3 mn
Stock-Based Comp., Other (Total)	-	-	−11,24 mn	-	-
Total Stock-Based Compensation	30,48 mn	52,91 mn	54,94 mn	61,43 mn	87,03 mn

Skatteperiod: December	2020	2021	2022	2023	2024
TILLGÅNGAR
Cash And Equivalents	960 mn	1,13 md	1,07 md	449 mn	480 mn
Short Term Investments	297 mn	-	-	-	23,63 mn
Trading Asset Securities, Total	-	299 mn	109 mn	1,18 md	7,72 md
Total Cash And Short Term Investments	1,26 md	1,43 md	1,18 md	1,63 md	8,23 md
Accounts Receivable, Total	46,48 mn	73,02 mn	116 mn	122 mn	194 mn
Other Receivables	15,44 mn	37,36 mn	21,6 mn	16,44 mn	97,44 mn
Total Receivables	61,93 mn	110 mn	137 mn	139 mn	291 mn
Inventory	65,04 mn	118 mn	1,29 mn	7,94 mn	10,7 mn
Prepaid Expenses	35,16 mn	64,63 mn	-	-	-
Restricted Cash	-	-	-	-	-
Total Current Assets	1,42 md	1,72 md	1,32 md	1,78 md	8,53 md
Gross Property Plant And Equipment	138 mn	290 mn	237 mn	220 mn	203 mn
Accumulated Depreciation	−53,26 mn	−68,89 mn	−71,36 mn	−70,43 mn	−77,72 mn
Net Property Plant And Equipment	213 mn	221 mn	165 mn	150 mn	125 mn
Long-term Investments	32,33 mn	26,91 mn	37,84 mn	21,38 mn	820 mn
Other Intangibles, Total	57,48 mn	53,79 mn	-	12,26 mn	12,62 mn
Accounts Receivable Long-Term	-	-	18,1 mn	15,79 mn	-
Deferred Tax Assets Long-Term	8,37 mn	13,52 mn	2,02 mn	925 tn	985 tn
Other Long-Term Assets, Total	31,04 mn	30,36 mn	-	-	19,41 mn
Total Assets	1,76 md	2,07 md	1,54 md	1,98 md	9,51 md
Skulder
Accounts Payable, Total	70,38 mn	64,56 mn	181 mn	91,61 mn	181 mn
Accrued Expenses, Total	36,43 mn	28,7 mn	-	51,73 mn	93,66 mn
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	14,07 mn	14,9 mn	14,73 mn	16,66 mn	16,04 mn
Current Income Taxes Payable	30,39 mn	-	-	-	-
Unearned Revenue Current, Total	53,18 mn	53,03 mn	-	-	-
Other Current Liabilities	151 mn	173 mn	-	125 mn	113 mn
Total Current Liabilities	355 mn	334 mn	195 mn	285 mn	403 mn
Long-Term Debt	-	648 mn	401 mn	-	285 mn
Long-Term Leases	116 mn	125 mn	108 mn	103 mn	90,39 mn
Unearned Revenue Non Current	44,59 mn	14,55 mn	-	-	-
Other Non Current Liabilities	16,74 mn	18,43 mn	19,06 mn	-	110 mn
Total Liabilities	533 mn	1,14 md	724 mn	387 mn	889 mn
Common Stock, Total	39,8 mn	43,63 mn	51,7 mn	58,75 mn	71,02 mn
Additional Paid In Capital	3,47 md	4,25 md	-	6,41 md	14,68 md
Retained Earnings	−2,29 md	−3,31 md	-	−4,89 md	−6,16 md
Treasury Stock	-	−71,89 mn	-	-	-
Comprehensive Income and Other	8,98 mn	14,16 mn	764 mn	22,7 mn	22,39 mn
Total Common Equity	1,23 md	928 mn	816 mn	1,59 md	8,62 md
Total Equity	1,23 md	928 mn	816 mn	1,59 md	8,62 md
Total Liabilities And Equity	1,76 md	2,07 md	1,54 md	1,98 md	9,51 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	39,55 mn	43,22 mn	51,47 mn	58,38 mn	70,65 mn
ECS Total Common Shares Outstanding	39,74 mn	43,22 mn	51,47 mn	58,38 mn	70,65 mn
Book Value / Share	30,94	21,47	15,85	27,28	121,96
Tangible Book Value	1,17 md	874 mn	816 mn	1,58 md	8,6 md
Tangible Book Value Per Share	29,49	20,22	15,85	27,07	121,78
Total Debt	130 mn	787 mn	524 mn	119 mn	392 mn
Net Debt	−1,13 md	−641 mn	−654 mn	−1,51 md	−8,65 md
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	14,4 mn	35,82 mn	1,29 mn	7,94 mn	10,7 mn
Inventories - Work In Process, Total	13,72 mn	29,59 mn	-	-	-
Inventories - Finished Goods, Total	36,92 mn	53,03 mn	-	-	-
Buildings, Total	34,1 mn	36,6 mn	-	-	-
Machinery, Total	101 mn	107 mn	82,82 mn	78,57 mn	84,91 mn
Full Time Employees	329	355	196	253	335

Skatteperiod: December	2020	2021	2022	2023	2024
Net Income	−847 mn	−1,02 md	−1,2 md	−704 mn	−1,08 md
Depreciation & Amortization - CF	23,1 mn	32,39 mn	102 mn	20,12 mn	23,12 mn
Amortization of Goodwill and Intangible Assets - (CF)	6,86 mn	7,86 mn	-	-	-
Depreciation & Amortization, Total	29,96 mn	40,25 mn	102 mn	20,12 mn	23,12 mn
Amortization of Deferred Charges, Total - (CF)	-	-	1,34 mn	1,2 mn	16,49 mn
(Gain) Loss From Sale Of Asset	-	2,7 mn	-	-	-
Asset Writedown & Restructuring Costs	12,74 mn	6,52 mn	−1,06 mn	4,71 mn	-
Stock-Based Compensation (CF)	30,48 mn	53,5 mn	52,58 mn	61,43 mn	87,03 mn
Net Cash From Discontinued Operations	-	-	13,5 mn	-	-
Other Operating Activities, Total	−12,98 mn	−130 mn	81,38 mn	139 mn	−101 mn
Change In Accounts Receivable	−7,72 mn	−64,49 mn	18,22 mn	−6,76 mn	−48,96 mn
Change In Inventories	−14,4 mn	−52,77 mn	50,69 mn	9,34 mn	−2,76 mn
Change In Accounts Payable	120 mn	−49,06 mn	−58,65 mn	39,84 mn	89,92 mn
Change in Other Net Operating Assets	-	-	-	9,68 mn	84,19 mn
Cash from Operations	−689 mn	−1,21 md	−942 mn	−426 mn	−931 mn
Capital Expenditure	−25,04 mn	−22,13 mn	−11,71 mn	−11,24 mn	−10,05 mn
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	−168 mn	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	−12,51 mn	−3,1 mn
Investment in Marketable and Equity Securities, Total	-	-	187 mn	−1,07 md	−7,32 md
Other Investing Activities, Total	−3,97 mn	4,01 mn	106 mn	-	-
Cash from Investing	−197 mn	−18,12 mn	281 mn	−1,09 md	−7,33 md
Long-Term Debt Issued, Total	-	648 mn	-	-	370 mn
Total Debt Issued	-	648 mn	-	-	370 mn
Long-Term Debt Repaid, Total	−29,22 mn	−14,72 mn	−450 mn	−543 mn	−16,44 mn
Total Debt Repaid	−29,22 mn	−14,72 mn	−450 mn	−543 mn	−16,44 mn
Issuance of Common Stock	833 mn	775 mn	1,08 md	1,56 md	8,52 md
Repurchase of Common Stock	-	−28,59 mn	-	−41,6 mn	−352 mn
Other Financing Activities, Total	−42,71 mn	−46,9 mn	−47,46 mn	−71,91 mn	−237 mn
Cash from Financing	761 mn	1,33 md	587 mn	907 mn	8,29 md
Foreign Exchange Rate Adjustments	3,74 mn	66,22 mn	13,68 mn	−7,24 mn	6,23 mn
Net Change in Cash	−121 mn	169 mn	−59,87 mn	−620 mn	30,99 mn
Kompletterande punkter
Cash Interest Paid	2,9 mn	3,3 mn	34,41 mn	25,25 mn	24,03 mn
Cash Income Tax Paid (Refund)	-	41,63 mn	−9,28 mn	−11,3 mn	−11,16 mn
Levered Free Cash Flow	−434 mn	−741 mn	−382 mn	−229 mn	−736 mn
Unlevered Free Cash Flow	−432 mn	−738 mn	−347 mn	−214 mn	−729 mn
Change In Net Working Capital	−38,17 mn	153 mn	−16,29 mn	−78,94 mn	35,45 mn
Net Debt Issued / Repaid	−29,22 mn	633 mn	−450 mn	−543 mn	353 mn

Skatteperiod: December	2020	2021	2022	2023	2024
Lönsamhet
Return on Assets	−30,08	−34,28	−28,21	−19,93	−13,81
Return on Total Capital	−37,62	−42,7	−33,31	−22,99	−14,8
Return On Equity %	−68,51	−94,4	−110,75	−58,43	−21,13
Return on Common Equity	−68,51	−94,4	−110,75	−58,43	−21,13
Marginalanalys
Gross Profit Margin %	74,37	59,39	100	99,07	87,44
SG&A Margin	132,51	217,47	259,18	62,99	644,47
EBITDA Margin %	−224,3	−350,07	−698,78	−161,83	−2,01 tn
EBITA Margin %	−227,01	−356,27	−782,86	−163,73	−2,02 tn
EBIT Margin %	−228,95	−358,96	−782,86	−163,73	−2,02 tn
Income From Continuing Operations Margin %	−239,65	−348,01	−928,6	−205,3	−1,72 tn
Net Income Margin %	−239,65	−348,01	−1,16 tn	−205,3	−1,72 tn
Net Avail. For Common Margin %	−239,65	−348,01	−928,6	−205,3	−1,72 tn
Normalized Net Income Margin	−151,25	−217,56	−498,09	−100,91	−1,13 tn
Levered Free Cash Flow Margin	−122,79	−253,28	−367,48	−66,8	−1,17 tn
Unlevered Free Cash Flow Margin	−122,27	−252,4	−334,03	−62,37	−1,16 tn
Tillgångsomslutning
Asset Turnover	0,21	0,15	0,06	0,19	0,01
Fixed Assets Turnover	2,09	1,35	0,54	2,17	0,46
Receivables Turnover (Average Receivables)	14,96	4,9	0,77	2,88	0,43
Inventory Turnover (Average Inventory)	-	1,3	-	0,69	0,85
Kortfristig likviditet
Current Ratio	4	5,15	6,73	6,25	21,14
Quick Ratio	3,71	4,6	6,73	6,23	21,11
Operating Cash Flow to Current Liabilities	−1,94	−3,63	−4,82	−1,5	−2,31
Days Sales Outstanding (Average Receivables)	24,47	74,55	472,24	126,7	850,51
Days Outstanding Inventory (Average Inventory)	-	281,82	-	526,71	433,05
Average Days Payable Outstanding	-	143	-	5,05 tn	4,69 tn
Cash Conversion Cycle (Average Days)	-	213,37	-	−4,4 tn	−3,41 tn
Långsiktig solvens
Total Debt/Equity	10,58	84,87	64,23	7,49	4,55
Total Debt / Total Capital	9,57	45,91	39,11	6,96	4,35
LT Debt/Equity	9,44	83,26	62,43	6,44	4,36
Long-Term Debt / Total Capital	8,54	45,04	38,01	5,99	4,17
Total Liabilities / Total Assets	30,23	55,13	47,01	19,55	9,35
EBIT / Interest Expense	−279,42	−256,71	−14,09	−21,73	−37,27
EBITDA / Interest Expense	−269,07	−246,87	−12,32	−20,95	−36,6
(EBITDA - Capex) / Interest Expense	−277,72	−252,28	−12,53	−21,38	−36,89
Total Debt / EBITDA	−0,17	−0,78	−0,74	−0,22	−0,31
Net Debt / EBITDA	1,45	0,63	0,92	2,8	6,95
Total Debt / (EBITDA - Capex)	−0,16	−0,76	−0,72	−0,22	−0,31
Net Debt / (EBITDA - Capex)	1,4	0,62	0,9	2,74	6,89
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	754,8	−17,19	−4,2	229,65	−81,71
Gross Profit, 1 Yr. Growth %	542,14	−33,87	6,57	226,58	−83,86
EBITDA, 1 Yr. Growth %	35,91	29,24	−5,46	−23,96	126,88
EBITA, 1 Yr. Growth %	36,42	29,96	4,08	−31,27	126,12
EBIT, 1 Yr. Growth %	37,59	29,83	4,08	−31,27	126,12
Earnings From Cont. Operations, 1 Yr. Growth %	48,15	20,24	27,91	−27,12	53,3
Net Income, 1 Yr. Growth %	48,15	20,24	18,07	−41,46	53,3
Normalized Net Income, 1 Yr. Growth %	47,54	19,1	10,03	−33,42	104,65
Diluted EPS Before Extra, 1 Yr. Growth %	30,51	7,61	18,68	−40,5	30,58
Accounts Receivable, 1 Yr. Growth %	6,09 tn	57,1	−24,65	5,83	97,91
Inventory, 1 Yr. Growth %	-	82,1	−98,91	517,03	34,82
Net Property, Plant and Equip., 1 Yr. Growth %	69,97	3,95	−25,27	−9,45	−16,42
Total Assets, 1 Yr. Growth %	10,16	17,35	−25,53	28,59	380,08
Tangible Book Value, 1 Yr. Growth %	−5,51	−25,41	−6,65	93,72	444,36
Common Equity, 1 Yr. Growth %	−1,08	−24,53	−12,06	95,22	440,97
Cash From Operations, 1 Yr. Growth %	68,2	75,98	−22,26	−54,83	118,67
Capital Expenditures, 1 Yr. Growth %	19,05	−11,62	−47,09	−4,01	−10,57
Levered Free Cash Flow, 1 Yr. Growth %	36,6	70,81	−35,2	−40,38	221,6
Unlevered Free Cash Flow, 1 Yr. Growth %	36,9	70,93	−40,84	−38,8	240,95
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	205,01	166,05	−26,41	77,71	−22,35
Gross Profit, 2 Yr. CAGR %	175,49	106,07	−26,41	86,56	−27,39
EBITDA, 2 Yr. CAGR %	33,9	33,55	11,59	−15,04	31,34
EBITA, 2 Yr. CAGR %	34,03	33,15	14,02	−15,29	24,66
EBIT, 2 Yr. CAGR %	34,6	33,65	14,02	−15,29	24,66
Earnings From Cont. Operations, 2 Yr. CAGR %	20,69	33,47	20,17	−3,45	5,7
Net Income, 2 Yr. CAGR %	20,69	33,47	19,15	−16,86	−5,27
Normalized Net Income, 2 Yr. CAGR %	34,65	32,56	10,92	−14,28	16,73
Diluted EPS Before Extra, 2 Yr. CAGR %	7,95	18,51	9,51	−15,97	−11,85
Accounts Receivable, 2 Yr. CAGR %	276,8	886,09	57,71	−10,7	29,39
Inventory, 2 Yr. CAGR %	-	-	−85,94	−74,12	188,42
Net Property, Plant and Equip., 2 Yr. CAGR %	269,19	32,92	−11,86	−17,74	−13
Total Assets, 2 Yr. CAGR %	19,7	13,7	−6,52	−2,14	148,46
Tangible Book Value, 2 Yr. CAGR %	2,46	−16,05	−16,56	34,48	224,74
Common Equity, 2 Yr. CAGR %	4,94	−13,59	−18,53	31,03	224,98
Cash From Operations, 2 Yr. CAGR %	22,17	72,05	16,96	−40,74	−0,61
Capital Expenditures, 2 Yr. CAGR %	149,04	2,57	−31,62	−28,73	−7,34
Levered Free Cash Flow, 2 Yr. CAGR %	−35,98	52,75	5,63	−37,69	38,47
Unlevered Free Cash Flow, 2 Yr. CAGR %	−36,19	52,97	5,57	−39,66	44,46
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	37,36	97,5	36,01	21,31	−16,72
Gross Profit, 3 Yr. CAGR %	29,08	71,21	36,46	20,93	−17,49
EBITDA, 3 Yr. CAGR %	48,14	32,33	8,16	−1,67	17,87
EBITA, 3 Yr. CAGR %	47,78	32,66	11,46	−3,59	17,51
EBIT, 3 Yr. CAGR %	48,2	32,99	11,46	−3,59	17,51
Earnings From Cont. Operations, 3 Yr. CAGR %	45,58	20,54	19,1	1,72	12,64
Net Income, 3 Yr. CAGR %	45,58	20,54	28,13	−5,98	1,95
Normalized Net Income, 3 Yr. CAGR %	45,08	29,26	12,66	−6,34	14,57
Diluted EPS Before Extra, 3 Yr. CAGR %	30,85	7,84	7,32	−10,64	−2,67
Accounts Receivable, 3 Yr. CAGR %	101,53	181,49	435,96	38,07	8,05
Inventory, 3 Yr. CAGR %	-	-	-	−50,4	−55,13
Net Property, Plant and Equip., 3 Yr. CAGR %	136,47	141,98	9,7	−11,07	−17,3
Total Assets, 3 Yr. CAGR %	34,68	18,91	−1,26	3,97	66,28
Tangible Book Value, 3 Yr. CAGR %	31,56	−7,83	−13,03	10,49	114,32
Common Equity, 3 Yr. CAGR %	33,67	−5,98	−13,08	9,02	110,2
Cash From Operations, 3 Yr. CAGR %	35,19	37,97	32,02	−14,82	−8,42
Capital Expenditures, 3 Yr. CAGR %	51,33	76,32	−17,74	−23,43	−23,13
Levered Free Cash Flow, 3 Yr. CAGR %	47,56	−11,21	6,36	−12,56	7,68
Unlevered Free Cash Flow, 3 Yr. CAGR %	51,05	−11,38	3,25	−11,81	7,47
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	13,49	4,85	−5,27	55,27	8,69
Gross Profit, 5 Yr. CAGR %	9,7	−2,77	−3,17	57,88	6,02
EBITDA, 5 Yr. CAGR %	60,2	55,23	24,41	4,65	16,99
EBITA, 5 Yr. CAGR %	58,05	54,34	26,78	4,68	16,64
EBIT, 5 Yr. CAGR %	58,32	54,57	26,78	4,68	16,64
Earnings From Cont. Operations, 5 Yr. CAGR %	49,35	45,28	28,61	3,9	13,55
Net Income, 5 Yr. CAGR %	49,35	45,28	34,37	3,9	13,55
Normalized Net Income, 5 Yr. CAGR %	48,14	44,3	24,24	3,25	14,34
Diluted EPS Before Extra, 5 Yr. CAGR %	34,88	29,7	16,23	−8,07	−0,81
Accounts Receivable, 5 Yr. CAGR %	−21,72	44,7	82,71	106,31	203,55
Net Property, Plant and Equip., 5 Yr. CAGR %	66,89	74,61	59,34	57,16	−0,01
Total Assets, 5 Yr. CAGR %	22,6	24,38	16,38	9,99	42,82
Tangible Book Value, 5 Yr. CAGR %	35,96	25,73	9,65	7,2	47,31
Common Equity, 5 Yr. CAGR %	37,27	27,24	9,65	7,37	47,3
Cash From Operations, 5 Yr. CAGR %	25,1	96,95	27,58	−1,6	17,85
Capital Expenditures, 5 Yr. CAGR %	44,03	53,47	10,14	22,72	−13,73
Levered Free Cash Flow, 5 Yr. CAGR %	18,11	50,55	23,13	−26,38	18,32
Unlevered Free Cash Flow, 5 Yr. CAGR %	20,2	45,63	22,61	−27,42	18,23